Sedana Medical, headquartered in Stockholm, Sweden and traded on Nasdaq Stockholm, was founded in 2005. It is a medical and pharmaceutical company that has been specializing in inhaled sedation to improve the patient‘s life during and after sedation since its establishment, and is a pioneer in this field.
Sedana Medical has direct sales in the Benelux countries, France, Germany, Great Britain, Scandinavian countries and Spain. The company works with external distributors in Asia, Australia, Canada, South and Central America, as well as in other parts of Europe.
Owing to the combined strengths of Sedaconda ACD (Anesthetic Protection Device) and the pharmaceutical product Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care.